| Management and Outcome of Acute Coronary Syndrome Patients in Relation to Prior History of Atrial Fibrillation. | |
| | |
MedLine Citation:
|
PMID: 22439969 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
BACKGROUND: The prognostic impact of atrial fibrillation (AF) in the setting of acute coronary syndrome (ACS) is controversial. Furthermore, there are limited real-world data on the management of ACS patients with history of AF. METHODS: The Global Registry of Acute Coronary Events (GRACE/GRACE2) and Canadian Registry of Acute Coronary Events (CANRACE) enrolled 14,285 patients across Canada between 1999 and 2008. Patients were stratified by the presence of history of AF. We compared clinical characteristics, medical therapies, cardiac procedures, and clinical outcomes between the 2 groups. RESULTS: Overall, 1333 of the enrolled patients (9.3%) had history of AF, of whom 51.5% presented with non-ST-segment elevation myocardial infarction, 29.5% with unstable angina, and 19.1% with ST-segment elevation myocardial infarction. Compared with the group without, patients with a history of AF less frequently received evidence-based antiplatelet and antithrombin therapies, left ventricle ejection fraction assessment, and coronary angiography (all P < 0.001); they also had higher unadjusted rates of in-hospital death, myocardial (re)infarction, and heart failure. However, in multivariable analysis, history of AF was not found to be independently associated with in-hospital mortality (adjusted odds ratio [OR] = 1.12; 95% confidence interval (CI), 0.73-1.73; P = 0.61) or death and/or myocardial reinfarction (adjusted OR = 1.15; 95% CI, 0.87-1.5; P = 0.34). CONCLUSIONS: History of AF is common among ACS patients. They received less evidence-based medical and invasive therapies than ACS patients without history of AF. History of AF is a negative independent predictor of in-hospital coronary angiography but was not found to be independently associated with adverse outcomes. |
| | |
Authors:
|
Darar Al Khdair; Lamia Alshengeiti; Basem Elbarouni; Raymond T Yan; Francois R Grondin; Frederick A Spencer; Sven Pallie; David Brieger; Kim A Eagle; Iqwal Mangat; Sheldon Singh; Shaun G Goodman; Andrew T Yan; |
Related Documents
:
|
7722129 - Treatment with beta-adrenergic blocking agents after myocardial infarction: from random... 16396269 - Relationship between selected echocardiographic variables before and after radioiodine ... 22471099 - The influence of left bundle branch-block and cardiac dyssynchrony on 2d-strain paramet... 22174579 - Comparison of outcome in 1809 patients treated with drug-eluting stents or bare-metal s... 22494199 - Recirculation usually precedes malignant edema in middle cerebral artery infarcts. 22499579 - Moving beyond a single perfusion threshold to define penumbra: a novel probabilistic mi... 10350199 - Midbrain infarction: a rare presentation of cryptococcal meningitis. 1234039 - Effect of glycerol treatment on the natural history of acute cerebral infarction. 1328889 - Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk fa... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-3-20 |
Journal Detail:
|
Title: The Canadian journal of cardiology Volume: - ISSN: 1916-7075 ISO Abbreviation: - Publication Date: 2012 Mar |
Date Detail:
|
Created Date: 2012-3-23 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8510280 Medline TA: Can J Cardiol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
Copyright © 2012 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved. |
Affiliation:
|
Terrence Donnelly Heart Centre, St Michael's Hospital, Toronto, Ontario, Canada; University of Toronto, Toronto, Ontario, Canada. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Mass Spectrometry-Based Proteomics and Network Biology.
Next Document: Electrocatalytically Active Graphene-Porphyrin MOF Composite for Oxygen Reduction Reaction.